Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

FDA Issues Action Plan for Rare Neuro Diseases

Man in wheelchair

The Food and Drug Administration published its blueprint to encourage new treatments for rare neurodegenerative disorders, including ALS. . . . → Read More: FDA Issues Action Plan for Rare Neuro Diseases

NASA Supporting Electric Alternative to Rocket Launch

SpinLaunch accelerator

A company creating an electric-powered launch technology says NASA agreed to a test later this year of a space satellite launched in low earth orbit. . . . → Read More: NASA Supporting Electric Alternative to Rocket Launch

U.S. to Buy Covid-19 Antiviral Drug in $1.2B Deal

Capsules

Two U.S. government health agencies agreed to purchase some 1.7 million doses of a Covid-19 antiviral drug, once the drug receives clearance from FDA. . . . → Read More: U.S. to Buy Covid-19 Antiviral Drug in $1.2B Deal

Medical Centers Join Covid-19 Digital Biomarker Trial

Phone with pinpointIQ

Three more medical centers are taking part in a clinical trial testing a mobile early-warning system that monitors Covid-19 patients with wearable sensors. . . . → Read More: Medical Centers Join Covid-19 Digital Biomarker Trial

Sensor in Works Detecting Covid-19 Airborne Virus

Graphene illustration

A company developing graphene bio-computer chips is applying its technology to sensors that quickly detect SARS-CoV-2 viruses in indoor air. . . . → Read More: Sensor in Works Detecting Covid-19 Airborne Virus

U.S. Supports Home Smartphone Covid-19 Test

Ellume home Covid-19 test

The U.S. government is funding large-scale production of Covid-19 home test kits that send results to the user’s smartphone. . . . → Read More: U.S. Supports Home Smartphone Covid-19 Test

US Govt to Buy 1.25M Regeneron Covid-19 Therapies

SARS-Cov-2 virus

The U.S. Department of Health and Human Services is buying up to 1.25 million more doses of Regeneron’s Covid-19 antibody therapy, for $2.63 billion. . . . → Read More: US Govt to Buy 1.25M Regeneron Covid-19 Therapies

BARDA Funding Vaccine Patch Clinical Trial

Nanopatch system

The U.S. government’s medical preparedness agency is funding a clinical trial of a patch that dispenses vaccines with a much lower dose than syringes. . . . → Read More: BARDA Funding Vaccine Patch Clinical Trial

Group Advancing Electronic Spinal Cord Injury Therapies

Spine

A consortium of academic and industry labs is integrating electronic sensors and neural stimulation therapies into an early treatment protocol for spinal cord injuries. . . . → Read More: Group Advancing Electronic Spinal Cord Injury Therapies

DoD Funding Variable Covid-19 Vaccine Technology

SARS-Cov-2 virus

The U.S. Department of Defense is funding work on a Covid-19 vaccine platform that can adjust its formula to protect against future mutations in the virus. . . . → Read More: DoD Funding Variable Covid-19 Vaccine Technology